Banks - Sector Update - 16 Nov 23
Banks - Sector Update - 16 Nov 23
Banks - Sector Update - 16 Nov 23
Banks
CRAR to shrink by ~80-95 bps
16 November 2023
B&K Securities is the trade name of Batlivala & Karani Securities India Pvt. Ltd.
Research Analyst SEBI Registration Number: INH300000211
SECTOR UPDATE
Banks
2
SECTOR UPDATE
Banks
(Rs mn) Existing Increase in Revised CET 1 CET 1 capital Revised CET 1 Change in
RWAs RWAs RWAs (%) (%) CET I
PVBs
HDFCB 2,17,42,260 11,57,621 2,28,99,881 17.3 37,61,411 16.4 -87bps
ICICIBC 1,20,64,060 8,85,465 1,29,49,525 15.26 18,40,976 14.2 -104bps
AXSB 89,70,721 9,41,668 99,12,388 14.56 13,06,137 13.2 -138bps
KMB 40,60,352 2,35,943 42,96,295 20.3 8,24,251 19.2 -111bps
IIB 35,03,760 1,80,701 36,84,461 16.33 5,72,164 15.5 -80bps
FB* 16,93,930 61,793 17,55,723 13.79 2,33,593 13.3 -49bps
RBL* 8,94,820 70,356 9,65,176 15.15 1,35,565 14.0 -110bps
CUBK* 3,37,784 7,227 3,45,011 19.02 64,247 18.6 -40bps
KVB 5,43,140 22,631 5,65,771 15.19 82,503 14.6 -61bps
PSUs
SBIN 2,87,00,440 26,21,256 3,13,21,696 9.94 28,52,824 9.1 -83bps
BOB 74,38,980 3,85,033 78,24,013 11.57 8,60,690 11.0 -57bps
PNB 70,80,860 5,91,583 76,72,443 10.23 7,24,372 9.4 -79bps
CBK 61,53,080 4,26,910 65,79,990 11.58 7,12,527 10.8 -75bps
BOI 37,95,090 2,16,760 40,11,850 12.6 4,78,181 11.9 -68bps
UNBK 61,07,566 4,39,404 65,46,970 13.05 7,97,037 12.2 -88bps
INBK 35,37,190 2,08,608 37,45,798 12.07 4,26,939 11.4 -67bps
Source: B&K Research. *For FB, CUBK and RBL Tier I capital ratios have been taken and not CET 1 ratios.
3
SECTOR UPDATE
Banks
ICICIBC, AXSB, IIB and FB registering higher growth PNB and BOB registering higher growth in
in unsecured retail book unsecured retail book
Growth in credit cards and PL higher than historical BOB and UNBK registering higher growth in
rates unsecured retail credit
4
SECTOR UPDATE
Banks
5
SECTOR UPDATE
Banks
6
SECTOR UPDATE
Banks
no. of companies
100 86
80 72
60
40
20
0
Top 100 Next 150 Residual
(Large Cap) (Mid Cap) (Small Cap)
B&K Securities is the trade name of Batlivala & Karani Securities India Pvt. Ltd.
LARGE CAP (Market Cap > USD 2 bn) MID & SMALL CAP (Market Cap < USD 2 bn)
BUY >+15% >+20%
HOLD +15% to -10 % +20% to -15 %
SELL <-10% <-15%
Disclaimer: This report was prepared, approved, published and distributed by Batlivala & Karani Securities India Private Limited (“B&K”) located
outside of the United States (a “non-US Group Company”), which accepts responsibility for its contents. It is distributed in the U.S. by Enclave Capital,
a U.S. registered broker dealer, on behalf of B&K, only to major U.S. institutional investors (as defined in Rule 15a-6 under the U.S. Securities Exchange
Act of 1934 (the “Exchange Act”) pursuant to the exemption in Rule 15a-6. Neither the report nor any analyst who prepared or approved the report is
subject to U.S. legal requirements or the Financial Industry Regulatory Authority, Inc. (“FINRA”) or other regulatory requirements pertaining to research
reports or research analysts. No non-US Group Company is registered as a broker-dealer under the Exchange Act or is a member of the Financial
Industry Regulatory Authority, Inc. or any other U.S. self-regulatory organization. Outside the United States, this report is distributed by B&K or an
authorized affiliate of B&K.
The report has been compiled or arrived from sources believed to be reliable and in good faith, but no representation or warranty, express or implied
is made as to their accuracy, completeness or correctness. B&K has not verified the factual accuracy, assumptions, calculations or completeness
of the information. Accordingly, B&K accepts no liability whatsoever for any direct or consequential loss or damage arising from (i) the use of this
communication (ii) reliance of any information contained herein, (iii) any error, omission or inaccuracy in any such Information or (iv) any action
resulting there from. B&K provides the information for the purpose of the intended recipient’s analysis and review and recipients are advised to verify
the factual accuracy, assumptions, calculations and completeness of the information.
This report was produced by B&K solely for information purposes and for the use of the recipient. It is not to be reproduced, redistributed under any
circumstances and is not to be copied or made available to any person other than the recipient. All estimates, expressions of opinion and other
subjective judgments contained herein are made as of the date of this document. Emerging securities markets may be subject to risks significantly
higher than more established markets. In particular, the political and economic environment, company practices and market prices and volumes may
be subject to significant variations. The ability to assess such risks may also be limited due to significantly lower information quantity and quality. By
accepting this document, you agree to be bound by all the foregoing provisions. This document does not constitute an offer of, or an invitation by or on
behalf of B&K or its affiliates or any other company to any person, to buy or sell any security.
The views of any Analyst reflected in this report are given in compliance with the Research Analyst Regulations, 2014. All analysts covering the
securities/ companies mentioned in this report have complied with the appropriate set of rules, regulations & procedures in their detailed coverage
report(s) of the respective securities/companies. It is important to note that any dispute with respect to this Research Report, would not have access
to stock exchange investor redressal forum or arbitration mechanism.
Analyst Certification: Each of the analysts identified in this report certifies, with respect to the companies or securities that the individual analyses,
that (1) the views expressed in this report reflect his or her personal views about all of the subject companies and securities and (2) no part of his or
her compensation was, is or will be directly or indirectly dependent on the specific recommendations or views expressed in this report.
SEBI DISCLAIMER: “Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any
assurance of returns to investors”.
Disclosures, applying to B&K and the Analyst (together with associates and family members)
7
SECTOR UPDATE
Banks
1. B&K or its Affiliates have not recently been the beneficial owners of 1% or more of the securities mentioned in this report.
2. B&K or its Affiliates have not managed or co-managed a public offering of the securities mentioned in the report in the past 12 months.
3. B&K or its Affiliates have not received compensation for investment banking services from the issuer of these securities in the past 12 months and
do not expect to receive compensation for investment banking services from the issuer of these securities within the next three months.
4. However, one or more person of B&K or its affiliates may, from time to time, have a long or short position in any of the securities mentioned herein
and may buy or sell those securities or options thereon either on their own account or on behalf of their clients.
5. B&K or its Affiliates may, to the extent permitted by law, act upon or use the above material or the conclusions stated above or the research or analysis
on which they are based before the material is published to recipients and from time to time provide investment banking, investment management
or other services for or solicit to seek to obtain investment banking, or other securities business from, any entity referred to in this report.
6. As of the publication of this report, Enclave Capital does not make a market in the subject securities.
Important US Regulatory Disclosures on Subject Companies
Enclave Capital is the distributor of this document in the United States of America. Any US customer wishing to effect transactions in any securities referred
to herein or options thereon should do so only by contacting a representative of Enclave Capital and any transaction effected by a U.S. customer in the
securities described in this report must be effected through Enclave Capital (19 West 44th Street, suite 1700, New York, NY 10036. Tel No: (646) 454 8600).